Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DPAG is the host Department for the annual Oxosome meetings, which bring together researchers from across Oxford with an interest in cell communication involving exosomes and other extracellular vesicles.  

The third annual meeting of Oxosome: the extracellular vesicle group organised by Deborah Goberdhan (DPAG), Dave Carter (Oxford Brookes), Eduard Willms (DPhil student, Wood lab, DPAG) and Maria Laura Tognoli (DPhil student, O’Neill lab, Dept of Oncology) was held on the afternoon of Thursday 1 November 2018 in the Sherrington Large Lecture Theatre with around 120 people participating.  

The talks showcased the quality and breadth of local research on extracellular vesicles, with speakers from a wide range of departments:  DPAG, Sir William Dunn School of Pathology, Kennedy Institute of Rheumatology, Dept of Oncology, Radcliffe Dept of Medicine, Nuffield Dept of Clinical Neurosciences and Biological and Medical Sciences at Oxford Brookes.  The talks spanned all the way from fundamental studies of vesicle biology to clinical disorders, including myocardial infarction, cancer, and neurodegenerative disease.

There was plenty of opportunity for interaction and discussion of collaborative work during the coffee break and subsequent wine reception.

Generous sponsorship from DPAG, IZON Science Ltd, EVOX Therapeutics Ltd, NanoView Bios, ONI Ltd and Analytik Ltd enabled the meeting to be held free of charge.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

Key exosome subtype in cancer progression identified

Collaborative work from DPAG and Oncology researchers has revealed a potential new pathway to block the production of a specific group of exosomes made in the cell’s recycling system that can promote the growth of cancerous tumours.

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.